ProMetic Life Sciences Inc.

ProMetic Life Sciences Inc., a biopharmaceutical company, engages in the research, development, manufacture, and marketing of drug therapeutics and protein technologies. Its In-House Therapeutics segment develops drug candidates for the treatment of hematological and nephrological disorders, and cancer. This segment focuses on developing drug therapeutics to treat blood-related disorders.

Ticker:
PLI
Exchange:
TSX (See More TSX Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?